E. Kicic et Tn. Palmer, INCREASED WHITE CELL ALDOSE REDUCTASE MESSENGER-RNA LEVELS IN DIABETIC-PATIENTS, Diabetes research and clinical practice, 33(1), 1996, pp. 31-36
This paper examines the question of whether diabetes in humans is asso
ciated with changes in aldose reductase and sorbitol dehydrogenase gen
e expression. The polyol pathway, which comprises the enzymes aldose r
eductase and sorbitol dehydrogenase, is recognised to play a central r
ole ill the pathogenesis of the diabetic complications Whilst it is kn
own that experimental diabetes in the rat is associated with increased
aldose reductase gene expression, possibly as an osmoregulatory respo
nse ro hyperglycaemia, little is known about aldose reductase and sorb
itol dehydrogenase gene expression in diabetes in humans. White cell a
ldose reductase mRNA levels were increased in patients with insulin-de
pendent (by 135%, P < 0.05) and non insulin-dependent (by 132%, P < 0.
05) diabetes compared to levels in healthy volunteers. Levels of glyco
sylated haemoglobin were also increased (P < 0.001) ill diabetes but t
here was no correlation between white cell aldose reductase mRNA and g
lycosylated haemoglobin levels. In contrast to aldose reductase, level
s of white cell sorbitol dehydrogenase mRNA were not affected by diabe
tes. These results establish for the first time that diabetic patients
show increases in white cell aldose reductase mRNA levels, possibly c
onsistent with increased aldose reductase gene expression This finding
may have implications for the use of aldose reductase inhibitors in t
he treatment of the diabetic complications.